文献速递静脉血栓栓塞慢性静脉疾病

深静脉血栓与髂静脉压迫综合征支架通畅性的系统评价与荟萃分析

Association between deep vein thrombosis and stent patency in symptomatic iliac vein compression syndrome: Systematic review and meta-analysis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-08-20

该系统评价与荟萃分析纳入5项研究共1050例患者、1169条下肢,比较非血栓性髂静脉病变(NIVL)、急性深静脉血栓(DVT)及血栓后综合征(PTS)患者支架置入后的主要通畅率。结果显示NIVL与急性DVT在6个月和12个月的主要通畅率无统计学差异,而NIVL优于PTS。

要点

  • NIVL与急性DVT支架6个月和12个月主要通畅率无统计学差异。
  • NIVL组6个月和12个月主要通畅率均优于PTS组。
  • 急性DVT与PTS相比,支架置入可能更倾向于急性DVT。

核心结论

  • NIVL与急性DVT下肢支架主要通畅率在6个月和12个月无统计学差异。
  • NIVL与PTS相比,PTS患者6个月和12个月支架主要通畅率更低。

研究设计与样本

  • 系统评价与荟萃分析,比较NIVL(组1)与急性DVT(组2)、NIVL(组1)与PTS(组3)。
  • 检索EMBASE、PubMed、Web of Science、Scopus、SciELO和LILACS数据库。
  • 纳入5项研究,共1050例参与者、1169条下肢。

主要发现

  • 支架腔内技术成功率:NIVL 99.6%、急性DVT 94.5%、PTS 96.5%(P = .0632)。
  • 6个月主要通畅率:NIVL 98.3% vs PTS 90.9%(OR 0.17;95% CI 0.06-0.48;P = .0008;I2 = 0%)。
  • 6个月主要通畅率:NIVL 100% vs 急性DVT 91.6%(OR 0.30;95% CI 0.06-2.32;P = .30;I2 = 0%)。
  • 12个月主要通畅率:NIVL 94.6% vs PTS 84.1%(OR 0.29;95% CI 0.14-0.63;P = .0008;I2 = 0%)。

关键数值与推荐

  • 6个月主要通畅率NIVL vs PTS有统计学差异(OR 0.17;95% CI 0.06-0.48;P = .0008)。
  • 12个月主要通畅率NIVL vs PTS有统计学差异(OR 0.29;95% CI 0.14-0.63;P = .0008)。
  • 6个月和12个月主要通畅率NIVL vs 急性DVT均无统计学差异(P = .30和P = .96)。

临床怎么用

  • NIVL与急性DVT支架通畅率相当,NIVL置入支架需考虑其他指征。
  • PTS患者支架通畅率较低,应优先考虑急性DVT的治疗而非PTS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The study intended to evaluate stent primary patency rates for patients with iliac vein obstruction related with iliac vein compression syndrome according to clinic presentation. METHODS: A systematic review and meta-analysis was conducted of studies that compared: unexposed patients with nonthrombotic iliac vein lesion (NIVL, group 1) vs exposed patients with iliac acute deep vein thrombosis (DVT, group 2); and NIVL (group 1) vs exposed patients with iliac vein obstruction and post-thrombotic syndrome (PTS, group 3). The following databases were searched: EMBASE, PubMed, Web of Science, Scopus, SciELO, and LILACS. Two reviewers independently selected the potential studies and extracted data. The pooled odds ratio (OR) and 95% confidence interval (95% CI) are shown for each outcome. RESULTS: Five studies with a total of 1050 participants and 1169 lower limbs were included. Five hundred eighty-eight lower limbs presented NIVL (50.3%), 91 lower limbs presented acute DVT (7.7%), and 490 lower limbs presented PTS (42%). The endovascular technical success rate of stenting did not differ in any of the groups: 99.6% in NIVL, 94.5% in acute DVT, and 96.5% in PTS (P = .0632). The primary stent patency rates in the 6-month follow-up were 98.3% in NIVL vs 90.9% in PTS, with a statistical difference showing reduced stent patency rates in PTS (OR, 0.17; 95% CI, 0.06-0.48; P = .0008; I2 = 0%), and 100% in the NIVL group vs 91.6% in acute DVT, with no statistical difference (OR, 0.30; 95% CI, 0.06-2.32; P = .30; I2 = 0%). The primary stent patency rates in the 12-month follow-up were 94.6% in NIVL vs 84.1% in PTS, with a statistical difference showing decreases stent patency rates in the PTS group (OR, 0.29; 95% CI, 0.14-0.63; P = .0008; I2 = 0%), and 91.1% in NIVL vs 90.9% in acute DVT, with no statistical difference (OR, 1.03; 95% CI, 0.26-4.07; P = .96; I2 = 0%). CONCLUSIONS: There is no statistical difference for the stent primary patency rates when the treatment is conducted in NIVL as compared with acute DVT lower limbs (at 6 and 12 months); therefore, other criteria must be considered for the indication of this treatment in NIVL patients. However, because there were better results of stent primary patency rates for NIVL vs PTS patients, this finding favors the treatment of acute DVT instead of PTS in lower limbs, once PTS renders smaller stent patency rates at 6 and 12 months.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Rodrigues LDS, Bertanha M, El Dib R, et al. Association between deep vein thrombosis and stent patency in symptomatic iliac vein compression syndrome: Systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32827731. doi:10.1016/j.jvsv.2020.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。